0001982444--12-312025Q22025-06-30false00019824442025-01-012025-06-300001982444us-gaap:AdditionalPaidInCapitalMember2025-01-012025-06-300001982444us-gaap:CommonStockMember2025-01-012025-06-300001982444bdmd:ExcelFinSpacLlcMember2023-08-032023-08-030001982444us-gaap:NoncontrollingInterestMember2025-06-300001982444us-gaap:NoncontrollingInterestMember2024-12-310001982444us-gaap:NoncontrollingInterestMember2024-06-300001982444us-gaap:NoncontrollingInterestMember2023-12-310001982444us-gaap:RetainedEarningsMember2025-06-300001982444us-gaap:ParentMember2025-06-300001982444us-gaap:AdditionalPaidInCapitalMember2025-06-300001982444us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-06-300001982444bdmd:StatutoryReserveMember2025-06-300001982444us-gaap:RetainedEarningsMember2024-12-310001982444us-gaap:ParentMember2024-12-310001982444us-gaap:AdditionalPaidInCapitalMember2024-12-310001982444us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001982444bdmd:StatutoryReserveMember2024-12-310001982444us-gaap:RetainedEarningsMember2024-06-300001982444us-gaap:ParentMember2024-06-300001982444us-gaap:AdditionalPaidInCapitalMember2024-06-300001982444us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300001982444bdmd:StatutoryReserveMember2024-06-300001982444us-gaap:RetainedEarningsMember2023-12-310001982444us-gaap:ParentMember2023-12-310001982444us-gaap:AdditionalPaidInCapitalMember2023-12-310001982444us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001982444bdmd:StatutoryReserveMember2023-12-310001982444us-gaap:PreferredStockMember2025-06-300001982444us-gaap:CommonStockMember2025-06-300001982444us-gaap:PreferredStockMember2024-12-310001982444us-gaap:CommonStockMember2024-12-310001982444us-gaap:CommonStockMember2024-06-300001982444us-gaap:CommonStockMember2023-12-310001982444us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMemberbdmd:EquityIncentivePlan2024Member2025-01-012025-06-300001982444us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberbdmd:EquityIncentivePlan2024Member2025-01-012025-06-300001982444bdmd:BaideSuzhouMember2025-06-3000019824442025-01-012025-06-300001982444us-gaap:TransferredOverTimeMember2025-01-012025-06-300001982444us-gaap:TransferredAtPointInTimeMember2025-01-012025-06-300001982444bdmd:OtherMedicalDevicesMember2025-01-012025-06-300001982444bdmd:MicrowaveAblationTherapeuticApparatusMember2025-01-012025-06-300001982444bdmd:MicrowaveAblationNeedlesMember2025-01-012025-06-300001982444bdmd:MicrowaveAblationDevicesMember2025-01-012025-06-300001982444bdmd:DistributorsMember2025-01-012025-06-300001982444bdmd:DirectCustomersMember2025-01-012025-06-300001982444us-gaap:TransferredOverTimeMember2024-01-012024-06-300001982444us-gaap:TransferredAtPointInTimeMember2024-01-012024-06-300001982444bdmd:OtherMedicalDevicesMember2024-01-012024-06-300001982444bdmd:MicrowaveAblationTherapeuticApparatusMember2024-01-012024-06-300001982444bdmd:MicrowaveAblationNeedlesMember2024-01-012024-06-300001982444bdmd:MicrowaveAblationDevicesMember2024-01-012024-06-300001982444bdmd:DistributorsMember2024-01-012024-06-300001982444bdmd:DirectCustomersMember2024-01-012024-06-300001982444srt:MinimumMemberus-gaap:FurnitureAndFixturesMember2025-06-300001982444srt:MinimumMemberus-gaap:EquipmentMember2025-06-300001982444srt:MinimumMemberbdmd:MedicalEquipmentMember2025-06-300001982444srt:MaximumMemberus-gaap:LeaseholdImprovementsMember2025-06-300001982444srt:MaximumMemberus-gaap:FurnitureAndFixturesMember2025-06-300001982444srt:MaximumMemberus-gaap:EquipmentMember2025-06-300001982444srt:MaximumMemberbdmd:MedicalEquipmentMember2025-06-300001982444us-gaap:VehiclesMember2025-06-300001982444us-gaap:LeaseholdImprovementsMember2025-06-300001982444us-gaap:FurnitureAndFixturesMember2025-06-300001982444us-gaap:EquipmentMember2025-06-300001982444bdmd:MedicalEquipmentMember2025-06-300001982444us-gaap:VehiclesMember2024-12-310001982444us-gaap:LeaseholdImprovementsMember2024-12-310001982444us-gaap:FurnitureAndFixturesMember2024-12-310001982444us-gaap:EquipmentMember2024-12-310001982444bdmd:MedicalEquipmentMember2024-12-310001982444us-gaap:NoncontrollingInterestMember2025-01-012025-06-300001982444us-gaap:NoncontrollingInterestMember2024-01-012024-06-300001982444bdmd:GrandFortuneCapitalLlcMemberus-gaap:SeriesAPreferredStockMember2024-09-300001982444us-gaap:SeriesAPreferredStockMember2024-09-300001982444bdmd:HaimeiWuMemberus-gaap:RelatedPartyMember2023-12-310001982444bdmd:BettersMedicalInvestmentHoldingsLimitedMemberus-gaap:RelatedPartyMember2025-06-300001982444us-gaap:RelatedPartyMember2025-06-300001982444bdmd:BettersMedicalInvestmentHoldingsLimitedMemberus-gaap:RelatedPartyMember2024-12-310001982444us-gaap:RelatedPartyMember2024-12-310001982444us-gaap:ParentMember2025-01-012025-06-300001982444us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-06-300001982444us-gaap:ParentMember2024-01-012024-06-300001982444us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-06-300001982444bdmd:TycoonChoiceGlobalLimitedMember2025-06-300001982444bdmd:SuzhouKangchuangMedicalCompanyLimitedMember2025-06-300001982444bdmd:ShengdeGuangzhouMedicalTechnologyCompanyLimitedMember2025-06-300001982444bdmd:RuikedeBiologicalTechnologyXiamenCompanyLimitedMember2025-06-300001982444bdmd:NanjingChangchengMedicalEquipmentCompanyLimitedMember2025-06-300001982444bdmd:JundeGuangzhouMedicalTechnologyCompanyLimitedMember2025-06-300001982444bdmd:HunanBaideMedicalTechnologyCompanyLimitedMember2025-06-300001982444bdmd:HenanRuideMedicalInstrumentCompanyLimitedMember2025-06-300001982444bdmd:HainanHaikeBaideMedicalCompanyLimitedMember2025-06-300001982444bdmd:GuokeBaideGuangdongMedicalCompanyLimitedMember2025-06-300001982444bdmd:GuizhouBaiyuanMedicalCompanyLimitedMember2025-06-300001982444bdmd:GuangzhouZhengdeCorporateManagementCompanyLimitedMember2025-06-300001982444bdmd:GuangzhouYideCapitalManagementCompanyLimitedMember2025-06-300001982444bdmd:GuangzhouFangdaMedicalTechnologyCompanyLimitedMember2025-06-300001982444bdmd:GuangzhouDedaoCapitalManagementCompanyLimitedMember2025-06-300001982444bdmd:GuangzhouBaihuiCorporateManagementCompanyLimitedMember2025-06-300001982444bdmd:ExcelfinAcquisitionCorpMember2025-06-300001982444bdmd:BettersMedicalNewcoLlcMember2025-06-300001982444bdmd:BairdMedicalLlcMember2025-06-300001982444bdmd:BaideSuzhouMedicalCompanyLimitedMember2025-06-300001982444bdmd:BaideMedicalInvestmentCompanyLimitedMember2025-06-300001982444bdmd:BaideGuangdongCapitalManagementCompanyLimitedMember2025-06-300001982444bdmd:WangJingMemberbdmd:RuikedeXiamenMember2019-07-170001982444bdmd:BankLoansMember2025-06-300001982444bdmd:FinancialLiabilitiesMember2024-12-310001982444bdmd:BankLoansMember2024-12-310001982444country:KY2025-01-012025-06-300001982444country:HK2025-01-012025-06-300001982444country:HK2024-01-012024-06-300001982444srt:MinimumMember2025-06-300001982444srt:MaximumMember2025-06-300001982444us-gaap:PatentsMember2025-06-300001982444us-gaap:ComputerSoftwareIntangibleAssetMember2025-06-300001982444us-gaap:PatentsMember2024-12-310001982444us-gaap:ComputerSoftwareIntangibleAssetMember2024-12-310001982444bdmd:NanjingChangchengMemberbdmd:ShortTermDebt2.8PercentDueInTenMonthsMemberus-gaap:SubsequentEventMember2025-10-012025-10-310001982444bdmd:NanjingChangchengMemberbdmd:ShortTermDebt2.8PercentDueInTenMonthsMemberus-gaap:SubsequentEventMember2025-10-310001982444bdmd:ShortTermDebt4.05PercentDue19thAugust2025Member2025-06-300001982444bdmd:ShortTermDebt3.85PercentDue19thNovember2025Member2025-06-300001982444bdmd:ShortTermDebt3.60PercentDue10thFebruary2026Member2025-06-300001982444bdmd:ShortTermDebt3.50PercentDue25thFebruary2026Member2025-06-300001982444bdmd:ShortTermDebt3.50PercentDue24thMarch2026Member2025-06-300001982444bdmd:ShortTermDebt3.50PercentDue14thMay2026Member2025-06-300001982444bdmd:ShortTermDebt3.30PercentDue3rdDecember2025Member2025-06-300001982444bdmd:ShortTermDebt3.10PercentDue5thDecember2025Member2025-06-300001982444bdmd:ShortTermDebt3.01PercentDue13thMarch2026Member2025-06-300001982444bdmd:ShortTermDebt3.00PercentDue27thDecember2025Member2025-06-300001982444bdmd:ShortTermDebt3.00PercentDue25thDecember2025Member2025-06-300001982444bdmd:ShortTermDebt2.80PercentDue20thMay2026Member2025-06-300001982444bdmd:ShortTermDebt2.80PercentDue11thJune2026Member2025-06-300001982444bdmd:ShortTermDebt2.55PercentDue5thNovember2025Member2025-06-300001982444bdmd:ShortTermDebt2.55PercentDue28thOctober2025Member2025-06-300001982444bdmd:ShortTermDebt4.15PercentDue27thMarch2025Member2024-12-310001982444bdmd:ShortTermDebt4.10PercentDue25thApril2025Member2024-12-310001982444bdmd:ShortTermDebt4.05PercentDue19thAugust2025Member2024-12-310001982444bdmd:ShortTermDebt3.95PercentDue14thMay2025Member2024-12-310001982444bdmd:ShortTermDebt3.90PercentDue29thJanuary2025Member2024-12-310001982444bdmd:ShortTermDebt3.85PercentDue19thNovember2025Member2024-12-310001982444bdmd:ShortTermDebt3.40PercentDue6thMay2025Member2024-12-310001982444bdmd:ShortTermDebt3.40PercentDue11thMay2025Member2024-12-310001982444bdmd:ShortTermDebt3.36PercentDue20thJune2025OneMember2024-12-310001982444bdmd:ShortTermDebt3.36PercentDue20thJune2025Member2024-12-310001982444bdmd:ShortTermDebt3.30PercentDue3rdDecember2025Member2024-12-310001982444bdmd:ShortTermDebt3.10PercentDue5thDecember2025Member2024-12-310001982444bdmd:ShortTermDebt3.00PercentDue26thMarch2025Member2024-12-310001982444bdmd:ShortTermDebt3.00PercentDue26thJune2025Member2024-12-310001982444bdmd:ShortTermDebt3.00PercentDue25thDecember2025Member2024-12-310001982444bdmd:ShortTermDebt3.00PercentDue11thJanuary2025Member2024-12-310001982444bdmd:ShortTermDebt2.55PercentDue5thNovember2025Member2024-12-310001982444bdmd:ShortTermDebt2.55PercentDue5thMay2025Member2024-12-310001982444bdmd:ShortTermDebt2.55PercentDue28thOctober2025Member2024-12-310001982444bdmd:ShortTermDebt2.55PercentDue13thMarch2025Member2024-12-310001982444bdmd:LongTermBankLoans3.10PercentIssuedOn18thDecember2024Due17thDecember2027Member2025-06-300001982444bdmd:LongTermBankLoans2.90PercentIssuedOn31stMarch2025Due30thMarch2028Member2025-06-300001982444bdmd:LongTermBankLoans2.90PercentIssuedOn14thApril2025Due30thMarch2028Member2025-06-300001982444bdmd:FinancialLiabilitiesMember2025-06-300001982444us-gaap:OperatingSegmentsMember2025-01-012025-06-300001982444us-gaap:OperatingSegmentsMember2024-01-012024-06-300001982444us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberbdmd:VendorTwoMember2025-01-012025-06-300001982444us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberbdmd:VendorThreeMember2025-01-012025-06-300001982444us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberbdmd:VendorOneMember2025-01-012025-06-300001982444us-gaap:AccountsPayableMemberus-gaap:SupplierConcentrationRiskMemberbdmd:VendorTwoMember2025-01-012025-06-300001982444us-gaap:AccountsPayableMemberus-gaap:SupplierConcentrationRiskMemberbdmd:VendorThreeMember2025-01-012025-06-300001982444us-gaap:AccountsPayableMemberus-gaap:SupplierConcentrationRiskMemberbdmd:VendorOneMember2025-01-012025-06-300001982444bdmd:CustomerTwoMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-06-300001982444bdmd:CustomerTwoMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-06-300001982444bdmd:CustomerOneMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-06-300001982444bdmd:CustomerOneMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-06-300001982444us-gaap:AccountsPayableMemberus-gaap:SupplierConcentrationRiskMemberbdmd:VendorTwoMember2024-01-012024-12-310001982444us-gaap:AccountsPayableMemberus-gaap:SupplierConcentrationRiskMemberbdmd:VendorOneMember2024-01-012024-12-310001982444bdmd:CustomerTwoMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-12-310001982444bdmd:CustomerThreeMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-12-310001982444bdmd:CustomerOneMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-12-310001982444us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberbdmd:VendorTwoMember2024-01-012024-06-300001982444us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberbdmd:VendorThreeMember2024-01-012024-06-300001982444us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberbdmd:VendorOneMember2024-01-012024-06-300001982444us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberbdmd:VendorFourMember2024-01-012024-06-300001982444us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberbdmd:VendorFiveMember2024-01-012024-06-300001982444bdmd:CustomerTwoMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-06-300001982444bdmd:CustomerThreeMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-06-300001982444bdmd:CustomerOneMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-06-300001982444bdmd:CustomerFourMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-06-300001982444srt:ParentCompanyMembersrt:ReportableLegalEntitiesMember2025-01-012025-06-300001982444srt:ParentCompanyMembersrt:ReportableLegalEntitiesMember2024-01-012024-06-3000019824442024-09-300001982444bdmd:J.v.b.FinancialGroupLlcMember2025-06-300001982444bdmd:GrandFortuneCapitalH.k.CompanyLimitedMember2025-06-300001982444bdmd:EquityIncentivePlan2024Member2025-06-300001982444bdmd:PublicStockholdersMemberbdmd:ExcelfinAcquisitionCorpMember2024-10-010001982444bdmd:ExcelfinPublicWarrantsMember2025-06-300001982444bdmd:ExcelfinAcquisitionCorpMemberbdmd:PublicWarrantsMember2024-10-0100019824442023-08-030001982444bdmd:BaideSuzhouMedicalCompanyLimitedMemberbdmd:RuikedeXiamenMember2019-07-170001982444bdmd:BaideSuzhouMedicalCompanyLimitedMemberbdmd:RuikedeXiamenMember2022-01-012022-12-310001982444bdmd:BaideSuzhouMedicalCompanyLimitedMemberbdmd:RuikedeXiamenMember2025-06-300001982444bdmd:BaideSuzhouMedicalCompanyLimitedMemberbdmd:RuikedeXiamenMember2024-12-310001982444bdmd:BaideSuzhouMedicalCompanyLimitedMemberbdmd:RuikedeXiamenMember2022-11-252022-11-250001982444bdmd:BaideSuzhouMedicalCompanyLimitedMemberbdmd:RuikedeXiamenMember2022-12-310001982444bdmd:BaideSuzhouMedicalCompanyLimitedMemberbdmd:RuikedeXiamenMember2022-11-250001982444bdmd:ExcelfinPublicWarrantsMember2025-01-012025-06-3000019824442025-04-012025-09-300001982444us-gaap:RestrictedStockUnitsRSUMemberbdmd:EquityIncentivePlan2024Member2025-01-012025-06-300001982444us-gaap:GeneralAndAdministrativeExpenseMember2025-01-012025-06-300001982444us-gaap:RestrictedStockUnitsRSUMemberbdmd:EquityIncentivePlan2024Member2024-01-012024-06-3000019824442024-01-012024-12-310001982444srt:ParentCompanyMembersrt:ReportableLegalEntitiesMember2025-06-300001982444bdmd:ChinaCiticBankMemberus-gaap:AssetPledgedAsCollateralMember2023-12-290001982444us-gaap:FinancialAssetNotPastDueMember2025-06-300001982444bdmd:FinancialAssetWithin90PastDueMember2025-06-300001982444bdmd:FinancialAssetGreaterThanOneYearPastDueMember2025-06-300001982444bdmd:FinancialAssetBetween6MonthsAndOneYearPastDueMember2025-06-300001982444bdmd:FinancialAssetBetween3And6MonthsPastDueMember2025-06-300001982444us-gaap:FinancialAssetNotPastDueMember2024-12-310001982444bdmd:FinancialAssetWithin90PastDueMember2024-12-310001982444bdmd:FinancialAssetGreaterThanOneYearPastDueMember2024-12-310001982444bdmd:FinancialAssetBetween6MonthsAndOneYearPastDueMember2024-12-310001982444bdmd:FinancialAssetBetween3And6MonthsPastDueMember2024-12-310001982444us-gaap:SupplierConcentrationRiskMember2025-06-300001982444us-gaap:SupplierConcentrationRiskMember2024-12-310001982444country:HKbdmd:UpToFirstHkd2MillionProfitsMember2025-01-012025-06-300001982444srt:MinimumMemberbdmd:ExcelfinAcquisitionCorpMember2024-10-012024-10-010001982444srt:MinimumMember2024-10-012024-10-010001982444bdmd:BettersMedicalNewcoLlcMembersrt:MinimumMember2023-08-032023-08-0300019824442023-08-032023-08-030001982444bdmd:GrandFortuneCapitalLlcMemberus-gaap:SeriesAPreferredStockMember2024-09-302024-09-3000019824442024-09-262024-09-260001982444bdmd:BaideSuzhouMember2025-02-280001982444bdmd:NanjingChangchengMember2023-09-012023-09-300001982444bdmd:NanjingChangchengMember2025-06-300001982444bdmd:BaideSuzhouMember2025-01-310001982444bdmd:NanjingChangchengMember2023-09-300001982444bdmd:HaimeiWuMemberus-gaap:RelatedPartyMember2024-01-012024-06-300001982444us-gaap:SeriesAPreferredStockMember2024-09-302024-09-300001982444country:CN2025-01-012025-06-300001982444country:CN2024-01-012024-06-300001982444bdmd:WuWenyuanMemberus-gaap:SeriesAPreferredStockMember2024-09-302024-09-300001982444bdmd:WuWenyuanMemberus-gaap:SeriesAPreferredStockMember2024-09-300001982444bdmd:ExcelfinAcquisitionCorpMember2024-01-012024-12-310001982444country:US2025-01-012025-06-300001982444country:US2024-01-012024-06-300001982444country:HKbdmd:ProfitsAboveHkd2MillionMember2025-01-012025-06-3000019824442024-10-012024-10-010001982444bdmd:BettersMedicalNewcoLlcMember2025-01-012025-06-300001982444bdmd:BettersMedicalNewcoLlcMember2023-08-032023-08-0300019824442024-06-3000019824442023-12-310001982444us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMember2025-01-012025-06-300001982444us-gaap:AccountsPayableMemberus-gaap:SupplierConcentrationRiskMember2025-01-012025-06-300001982444us-gaap:AccountsPayableMemberus-gaap:SupplierConcentrationRiskMember2024-01-012024-12-310001982444us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMember2024-01-012024-06-300001982444us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-06-300001982444us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-06-300001982444us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-12-310001982444us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-06-3000019824442024-10-010001982444srt:ParentCompanyMembersrt:ReportableLegalEntitiesMember2024-12-310001982444bdmd:ExcelfinAcquisitionCorpMemberbdmd:PublicWarrantsMember2024-10-012024-10-010001982444bdmd:ExcelfinAcquisitionCorpMember2024-12-310001982444bdmd:ExcelfinAcquisitionCorpMember2023-08-032023-08-030001982444bdmd:ExcelfinAcquisitionCorpMember2024-10-012024-10-010001982444country:CNbdmd:ProfitsExceedingRmb1MillionAndUpToRmb3MillionMember2025-01-012025-06-300001982444country:CNbdmd:UpToFirstRmb3MillionProfitsMember2025-01-012025-06-300001982444country:CNbdmd:UpToFirstRmb1MillionProfitsMember2025-01-012025-06-300001982444us-gaap:RetainedEarningsMember2025-01-012025-06-300001982444bdmd:StatutoryReserveMember2025-01-012025-06-300001982444us-gaap:RetainedEarningsMember2024-01-012024-06-300001982444bdmd:StatutoryReserveMember2024-01-012024-06-300001982444bdmd:ExcelfinAcquisitionCorpMember2024-10-0100019824442025-06-3000019824442024-12-310001982444srt:MinimumMember2025-01-012025-06-300001982444srt:MaximumMember2025-01-012025-06-300001982444srt:MinimumMember2024-01-012024-06-300001982444srt:MaximumMember2024-01-012024-06-3000019824442024-01-012024-06-30bdmd:periodbdmd:Dbdmd:segmentiso4217:USDxbrli:sharesxbrli:pureiso4217:USDxbrli:sharesbdmd:customerbdmd:itemiso4217:CNYiso4217:HKDbdmd:subsidiary

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of December 2025

Commission File Number 001-42300

Baird Medical Investment Holdings Limited

Room 202, 2/F, Baide Building, Building 11, No.15

Rongtong Street, Yuexiu District, Guangzhou,

Peoples Republic of China

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒

Form 40-F ☐

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Dated: December 5, 2025

	By:	/s/ Haimei Wu
	Name: Haimei Wu
	Title: Chairwoman and Chief Executive Officer

EXHIBIT INDEX


Exhibit Number		Description
99.1		Unaudited Interim Consolidated Financial Statements as of December 31, 2024 and June 30, 2025, and the for the Six Months Ended June 30, 2024 and 2025
99.2		Management’s Discussion and Analysis of Financial Condition and Results of Operations
101.INS		Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH		Inline XBRL Taxonomy Extension Schema Document
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

Baird Medical Investment Holdings Ltd 6-K